临床试验/ISRCTN12809144

ISRCTN12809144已完成未知

A prospective observational study assessing the clinical benefit of Toujeo initiation after oral antidiabetic drug failure in insulin naïve patients with type 2 diabetes mellitus

Sanofi-Aventis Deutschland GmbH0 个研究点目标入组 1,748 人开始时间: 2019年6月25日最近更新: 2024年7月15日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方: Sanofi-Aventis Deutschland GmbH
入组人数: 1,748

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

2016 Abstract results in https://dx.doi.org/10.1055/s-0036-1580970 conference abstract 2018 Abstract results in https://dx.doi.org/10.1055/s-0038-1641916 conference abstract 2018 Abstract results in https://diabetes.diabetesjournals.org/content/67/Supplement_1/1027-P conference abstract 2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/31903680 results (added 02/04/2020) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32753920/ (added 04/07/2024)

研究设计

研究类型: Observational

入排标准

性别: All

入选标准

•1. Patients with type 2 diabetes (oral antidiabetic drugs).
•2. Adults and Seniors: Age at least 18 years, no upper age limit.
•3. HbA1c between 7.5% to 10.0%.
•4. Ability and willingness to perform blood glucose self-monitoring.

排除标准

•1. Type 1 diabetes.
•2. Contraindications for a therapy with insulin glargine 300 U/mL.
•3. Any kind of existing insulin therapy.
•4. Patients with known cancer disease.
•5. Pregnancy.
•6. Drug or alcohol abuse.
•7. Dementia or general incapacity to understand the content of the observational study.

研究者

发起方

Sanofi-Aventis Deutschland GmbH

相似试验

进行中（未招募）

ACIT-2: An observational study investigating the systemic inflammatory, coagulation and genomic response in humans to severe injury and bleeding after major trauma

ISRCTN12962642Queen Mary University of London5,000

Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural EffusionsRespiratory DiseaseLung CancerPleural Effusion

NCT03661801University of Oxford313

Efficacy of tocilizumab in patients with rheumatoid arthritisRheumatoid arthritis

ISRCTN21216199niversity of Leeds (UK)15

Minimally invasive oesophageal adenocarcinoma sentinel node biopsy 4.0pper Gastro-Intestinal CancerMalignant neoplasm of oesophagusCancer

ISRCTN71969151ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)40

进行中（未招募）

A Study with additional chart review to evaluate clinical and biochemical characteristics and disease progression in patients with mucopolysaccharidosis type IIIBMucopolysaccharidosis type IIIBE76.2

RBR-3rx9fjHospital de Clínicas de Porto Alegre